SK13692001A3 - Taxány substituované v polohe C10 esterovou skupinou - Google Patents

Taxány substituované v polohe C10 esterovou skupinou Download PDF

Info

Publication number
SK13692001A3
SK13692001A3 SK1369-2001A SK13692001A SK13692001A3 SK 13692001 A3 SK13692001 A3 SK 13692001A3 SK 13692001 A SK13692001 A SK 13692001A SK 13692001 A3 SK13692001 A3 SK 13692001A3
Authority
SK
Slovakia
Prior art keywords
pyridyl
thienyl
taxane
alkyl
furyl
Prior art date
Application number
SK1369-2001A
Other languages
English (en)
Slovak (sk)
Inventor
Robert A. Holton
Original Assignee
Florida State University Research Foundation, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Florida State University Research Foundation, Inc. filed Critical Florida State University Research Foundation, Inc.
Publication of SK13692001A3 publication Critical patent/SK13692001A3/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65DCONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D83/00Containers or packages with special means for dispensing contents
    • B65D83/14Containers for dispensing liquid or semi-liquid contents by internal gaseous pressure, i.e. aerosol containers comprising propellant
    • B65D83/75Aerosol containers not provided for in groups B65D83/16 - B65D83/74
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mechanical Engineering (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SK1369-2001A 2000-02-02 2001-02-02 Taxány substituované v polohe C10 esterovou skupinou SK13692001A3 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17978200P 2000-02-02 2000-02-02
PCT/US2001/003623 WO2001057032A1 (en) 2000-02-02 2001-02-02 C10 ester substituted taxanes as antitumor agents

Publications (1)

Publication Number Publication Date
SK13692001A3 true SK13692001A3 (sk) 2002-07-02

Family

ID=22657972

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1369-2001A SK13692001A3 (sk) 2000-02-02 2001-02-02 Taxány substituované v polohe C10 esterovou skupinou

Country Status (25)

Country Link
EP (1) EP1165553B1 (https=)
JP (1) JP2003522172A (https=)
CN (1) CN1380882A (https=)
AT (1) ATE432928T1 (https=)
AU (1) AU782150B2 (https=)
BG (1) BG64889B1 (https=)
BR (1) BR0104354A (https=)
CA (1) CA2368274C (https=)
CZ (1) CZ20013430A3 (https=)
DE (1) DE60138853D1 (https=)
GE (1) GEP20043323B (https=)
HU (1) HUP0600302A2 (https=)
IL (1) IL145638A (https=)
MX (1) MXPA01009905A (https=)
NO (1) NO327910B1 (https=)
NZ (1) NZ514382A (https=)
PL (1) PL202957B1 (https=)
RO (1) RO121270B1 (https=)
RU (1) RU2262506C2 (https=)
SK (1) SK13692001A3 (https=)
TR (1) TR200102858T1 (https=)
TW (1) TWI299732B (https=)
UA (1) UA75039C2 (https=)
WO (1) WO2001057032A1 (https=)
ZA (1) ZA200108055B (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6649632B2 (en) 2000-02-02 2003-11-18 Fsu Research Foundation, Inc. C10 ester substituted taxanes
CA2354471A1 (en) * 2001-07-31 2003-01-31 Florida State University Research Foundation, Inc. C10 ester substituted taxanes
SG129990A1 (en) * 2001-08-01 2007-03-20 Univ Florida State Res Found C10 ester substituted taxanes
HN2005000054A (es) 2004-02-13 2009-02-18 Florida State University Foundation Inc Taxanos sustituidos con esteres de ciclopentilo en c10
US20060189679A1 (en) * 2005-02-14 2006-08-24 Florida State University Research Foundation, Inc. C10 cyclopropyl ester substituted taxane compositions
JP2011517455A (ja) * 2008-03-31 2011-06-09 フロリダ・ステイト・ユニバーシティ・リサーチ・ファウンデイション・インコーポレイテッド C(10)エチルエステルおよびc(10)シクロプロピルエステル置換タキサン

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2601675B1 (fr) * 1986-07-17 1988-09-23 Rhone Poulenc Sante Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent
US5250683A (en) * 1991-09-23 1993-10-05 Florida State University Certain substituted taxanes and pharmaceutical compositions containing them
US5243045A (en) * 1991-09-23 1993-09-07 Florida State University Certain alkoxy substituted taxanes and pharmaceutical compositions containing them
IL108443A0 (en) * 1993-01-29 1994-04-12 Univ Florida State C7 taxane derivatives and pharmaceutical compositions containing them
IL109051A0 (en) * 1993-03-22 1994-06-24 Univ Florida State Taxanes having an amino substituted side-chain and pharmaceutical compositions containing them
ATE284689T1 (de) * 1993-03-22 2005-01-15 Univ Florida State Pharmazeutische zusammenstellungen enthaltende eine furyl oder thienyl substituierte seitenkette
ATE209489T1 (de) * 1993-03-22 2001-12-15 Univ Florida State Taxane mit pyridyl-substituierter seitenkette
US5475011A (en) * 1993-03-26 1995-12-12 The Research Foundation Of State University Of New York Anti-tumor compounds, pharmaceutical compositions, methods for preparation thereof and for treatment
US6100411A (en) * 1994-10-28 2000-08-08 The Research Foundation Of State University Of New York Taxoid anti-tumor agents and pharmaceutical compositions thereof
EP0788493A1 (en) * 1994-10-28 1997-08-13 The Research Foundation Of State University Of New York Taxoid derivatives, their preparation and their use as antitumor agents
WO1997044026A1 (en) * 1996-05-22 1997-11-27 Neuromedica, Inc. Compositions comprising conjugates of cis-docosahexaenoic acid and taxotere
US5795909A (en) * 1996-05-22 1998-08-18 Neuromedica, Inc. DHA-pharmaceutical agent conjugates of taxanes
CA2314071A1 (en) * 1997-12-19 1999-07-01 Kabushiki Kaisha Yakult Honsha Taxane derivatives
JP2003026673A (ja) * 1999-03-05 2003-01-29 Asahi Kasei Corp 骨形成促進剤

Also Published As

Publication number Publication date
IL145638A (en) 2011-05-31
PL351380A1 (en) 2003-04-07
UA75039C2 (en) 2006-03-15
NZ514382A (en) 2004-05-28
PL202957B1 (pl) 2009-08-31
NO20014754L (no) 2001-11-29
NO327910B1 (no) 2009-10-19
EP1165553B1 (en) 2009-06-03
BG64889B1 (bg) 2006-08-31
TWI299732B (en) 2008-08-11
BR0104354A (pt) 2002-01-02
CZ20013430A3 (cs) 2002-04-17
CN1380882A (zh) 2002-11-20
TR200102858T1 (tr) 2002-12-23
CA2368274A1 (en) 2001-08-09
WO2001057032A1 (en) 2001-08-09
AU3480901A (en) 2001-08-14
CA2368274C (en) 2009-10-13
GEP20043323B (en) 2004-02-10
IL145638A0 (en) 2002-06-30
NO20014754D0 (no) 2001-10-01
JP2003522172A (ja) 2003-07-22
EP1165553A1 (en) 2002-01-02
BG105965A (en) 2002-07-31
MXPA01009905A (es) 2003-08-20
AU782150B2 (en) 2005-07-07
HUP0600302A2 (en) 2006-07-28
DE60138853D1 (de) 2009-07-16
ZA200108055B (en) 2003-12-01
ATE432928T1 (de) 2009-06-15
RO121270B1 (ro) 2007-02-28
RU2262506C2 (ru) 2005-10-20

Similar Documents

Publication Publication Date Title
RU2265017C2 (ru) С7 сложноэфирзамещенные таксаны в качестве противоопухолевых средств
US20020068755A1 (en) C10 heterosubstituted acetate taxanes
US6660866B2 (en) C10 carbonate substituted taxanes
US6673833B2 (en) C7 heterosubstituted acetate taxanes
US7226944B2 (en) Taxanes having a C7 carbonate substituent
US6649632B2 (en) C10 ester substituted taxanes
SK13692001A3 (sk) Taxány substituované v polohe C10 esterovou skupinou
US6750245B2 (en) C7 carbamate substituted taxanes
HUP0103245A2 (hu) C10 észter szubsztituált taxánok

Legal Events

Date Code Title Description
FB9A Suspension of patent application procedure